Gufic Biosciences Ltd GUFICBIO-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:23 PM IST
118.40quote price arrow up+0.85 (+0.72%)
Volume
89,321
52 week range
37.00 - 137.45

...

Loading . . .

KEY STATS

  • Open117.00
  • Day High120.30
  • Day Low116.60
  • Prev Close117.55
  • 52 Week High137.45
  • 52 Week High Date01/05/21
  • 52 Week Low37.00
  • 52 Week Low Date03/23/20
  • Market Cap125.97M
  • Shares Out77.83M
  • 10 Day Average Volume196,202.1
  • Dividend0.05
  • Dividend Yield0.04%
  • Beta
  • 1 Year % Change94.1

RATIOS/PROFITABILITY

  • EPS (TTM)3.92
  • P/E (TTM)30.23
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/03/2020
  • Div Amount0.05
  • Split Date-
  • Split Factor-

Latest Gufic Biosciences Ltd News

There is no recent news for this security.

Latest GUFICBIO-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Pharma, including Formulations and Bulk Drugs, and Consumer. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark...
Jayesh Choksi
Chairman
Pranav Choksi
Chief Executive Officer
Devkinandan Roonghta
Chief Financial Officer
Address
Gufic House
Sobhash Road, Vile Parle East
Mumbai
400057
India